ARTICLE | Company News
Intradigm, Sequitur RNAi deal
June 13, 2003 7:00 AM UTC
Intradigm (Rockville, Md.) and Sequitur (Natick, Mass.) partnered to research and develop RNAi-based therapeutics. Under the deal, the companies will cross-license respective related technologies, inc...